GLPBio

Ponasterone A

Catalog No.: GC44667Purity:>98.00%Synonyms: 25-Deoxyecdysterone
Ponasterone A is a high-affinity ecdysone receptor agonist, belonging to the plant ecdysteroid class of compounds.

Products are for research use only. Not for human use. We do not sell to patients.


Ponasterone A
Cas No.: 13408-56-5
1mgIn Stock
$56.00
1
5mgIn Stock
$252.00
1

Citations

No citations are currently available for this product. Below are selected publications citing GlpBio products.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Description

Ponasterone A is a high-affinity ecdysone receptor agonist, belonging to the plant ecdysteroid class of compounds[1-2]. Ponasterone A can serve as an effective modulator of gene expression in cells and transgenic animals, enabling rapid switching on and off of reporter genes[3-4].

In vitro, EcR293 clone-11 sub-1 cells were treated with Ponasterone A (1–10μM) for 3 weeks. Ponasterone A significantly induced iNOS expression, promoted the production of nitric oxide, and upregulated the mRNA expression of Fas and FasL[5]. Human Simpson‑Golabi‑Behmel syndrome adipocytes treated with Ponasterone A (5–50μM), Ponasterone A did not significantly affect lipid accumulation or basal lipolysis, nor did Ponasterone A alter isoproterenol-stimulated lipolysis[6].

In vivo, FVB mice carrying the MMTV-VgEcR/RXRα and (E/GRE)3β-Gal triple transgene were intraperitoneally injected with Ponasterone A (750μg) (either 24 hours after a single injection or via subcutaneous implantation of sustained-release pellets for 10 days). Ponasterone A induced uniform and sustained expression of the β-galactosidase gene in mammary epithelial cells, with no significant tissue toxicity or abnormal mammary development[7]. Tumor-bearing nude mice (with C8161 pVgRXR siGRM1 A13 cells) were treated intraperitoneally with Ponasterone A (10mg/kg) twice weekly (starting when tumor volume reached 10–20mm³, lasting 37–42 days). Ponasterone A significantly inhibited tumor growth, increased the proportion of cleaved Caspase-3-positive cells, and decreased the proportion of Ki-67-positive cells[8].

References:
[1] Hansen KØ, Isaksson J, Glomsaker E, et al. Ecdysteroids from the Arctic Bryozoan Alcyonidium gelatinosum. Molecules. 2018 Jun 19;23(6):1481.
[2] Gu Y, Ihara Y. Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules. J Biol Chem. 2000 Jun 16;275(24):17917-20.
[3] Xiao YY, Beilstein MA, Wang MC, et al. Development of a ponasterone A-inducible gene expression system for application in cultured skeletal muscle cells. Int J Biochem Cell Biol. 2003 Jan;35(1):79-85.
[4] McCarthy JF. Ponasterone A: a new ecdysteroid from the embryos and serum of brachyuran crustaceans. Steroids. 1979 Dec;34(7):799-806.
[5] Xu W, Liu L, Charles IG. Microencapsulated iNOS-expressing cells cause tumor suppression in mice. FASEB J. 2002 Feb;16(2):213-5.
[6] Todorova V, Savova MS, Ivanova S, et al. Anti-Adipogenic Activity of Rhaponticum carthamoides and Its Secondary Metabolites. Nutrients. 2023 Jul 7;15(13):3061.
[7] Albanese C, Reutens AT, Bouzahzah B, et al. Sustained mammary gland-directed, ponasterone A-inducible expression in transgenic mice. FASEB J. 2000 May;14(7):877-84.
[8] Wangari-Talbot J, Wall BA, Goydos JS, et al. Functional effects of GRM1 suppression in human melanoma cells. Mol Cancer Res. 2012 Nov;10(11):1440-50.

Protocol

Cell experiment [1]:

Cell lines

EcR293 clone-11 sub-1 human fetal kidney cells (inducible iNOS expression system)

Preparation Method

EcR293 clone-11 sub-1 cells were maintained in standard culture medium and microencapsulated within a semipermeable alginate-poly-L-lysine membrane. Cells were treated with Ponasterone A at concentrations of 1μM or 10μM for specified durations to induce iNOS expression.

Reaction Conditions

1–10μM; time-dependent treatment (up to 3 weeks in vitro)

Applications

Ponasterone A significantly induced iNOS expression in a dose-dependent manner. Ponasterone A also triggered concomitant upregulation of Fas and FasL mRNA levels, and enhanced NO production comparable to cytokine-activated macrophages.

Animal experiment [2]:

Animal models

Athymic nude mice bearing human melanoma xenografts

Preparation Method

Mice were subcutaneously inoculated with C8161 pVgRXR siGRM1 A13 or control cells. When tumor volumes reached 10–20mm³, mice received Ponasterone A (10mg/kg) or vehicle via intraperitoneal injection twice weekly for 37–42 days.

Dosage form

10mg/kg; i.p.; twice weekly.

Applications

Ponasterone A administration significantly suppressed tumor growth, increased cleaved Caspase-3-positive cells, and decreased Ki-67 proliferation marker expression in GRM1-silenced xenografts.

References:
[1] Xu W, Liu L, Charles IG. Microencapsulated iNOS-expressing cells cause tumor suppression in mice. FASEB J. 2002 Feb;16(2):213-5.
[2] Wangari-Talbot J, Wall BA, Goydos JS, et al. Functional effects of GRM1 suppression in human melanoma cells. Mol Cancer Res. 2012 Nov;10(11):1440-50.

Product Documents

Purity:>98.00%Appearance:A solid

Chemical Properties

CAS No.
13408-56-5
Synonyms
25-Deoxyecdysterone
SMILES
O=C1[C@]2([H])C[C@@H](O)[C@@H](O)C[C@]2(C)[C@]3([H])C([C@@](CC[C@]4([H])[C@]([C@H](O)CCC(C)C)(O)C)(O)[C@]4(C)CC3)=C1
Molecular Formula
C27H44O6
Molecular Weight
464.6
Solubility
DMF: 3 mg/mL,DMSO: 1 mg/mL,Ethanol: 5 mg/mL,Ethanol:PBS (pH 7.2)(1:2): 0.3 mg/mL,Methanol: Soluble
Storage
Store at -20°C
General tips
Select a suitable solvent according to the product solubility data. Once prepared, aliquot the stock solution to avoid repeated freeze-thaw cycles.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.

CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility

g/mol

Reviews

Review for Ponasterone A

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%